Thyroid eye disease: From pathogenesis to targeted therapies. | Taiwan J Ophthalmol;12(1): 3-11, 2022. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Thyroid eye disease: From pathogenesis to targeted therapies.

Yoon, Jin Sook; Kikkawa, Don O.

Affiliation

Yoon JS; Department of Ophthalmology, The Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Kikkawa DO; Division of Oculofacial Plastic and Reconstructive Surgery, University of California San Diego, California, United States of America.

Taiwan J Ophthalmol ; 12(1): 3-11, 2022.

Article in En | MEDLINE | ID: mdl-35399971

Key words

Autoimmune; insulin growth factor-1 receptor; orbital fibroblast; pathogenesis; thyroid eye disease; thyroid-stimulating hormone receptor

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies Language: En Journal: Taiwan J Ophthalmol Year: 2022 Document type: Article Country of publication: India

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies Language: En Journal: Taiwan J Ophthalmol Year: 2022 Document type: Article Country of publication: India